tiprankstipranks
Trending News
More News >
Orthofix International (OFIX)
:OFIX
US Market
Advertisement

Orthofix (OFIX) Earnings Dates, Call Summary & Reports

Compare
86 Followers

Earnings Data

Report Date
Mar 03, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.19
Last Year’s EPS
-0.75
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 04, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
Orthofix demonstrated strong revenue growth and operational efficiency, with significant contributions from the U.S. Spine and Orthopedics segments. Despite challenges such as pricing pressure and product discontinuation, the company maintained positive cash flow and expanded EBITDA margins.
Company Guidance
In the Orthofix Third Quarter 2025 Earnings Call, the company provided a detailed overview of its financial performance and guidance. Orthofix reported a total global net sales increase of 6% year-over-year, reaching $203.4 million, driven by strong growth in the U.S. Spine and Orthopedics segments. The U.S. Spine Fixation segment saw net sales increase by 8% with procedural volume up 10%, highlighting the success of distributor transitions and the adoption of their 7D FLASH navigation system. The Orthopedics business achieved a 19% growth in the U.S., supported by new product launches such as TrueLok Elevate. The company also recorded a seventh consecutive quarter of adjusted EBITDA margin expansion, with a non-GAAP adjusted EBITDA of $24.6 million, representing 12.1% of net sales. Orthofix narrowed its full-year pro forma net sales guidance to a range of $810 million to $814 million and adjusted its EBITDA guidance to a range of $84 million to $86 million, expecting continued positive free cash flow generation. The company is strategically positioning itself for sustainable growth with a focus on innovation, commercial execution, and operational efficiency.
Strong Revenue Growth
Orthofix reported a 6% year-over-year increase in global net sales reaching $203.4 million, with significant contributions from the U.S. Spine and Orthopedics segments.
U.S. Spine Fixation Segment Performance
The U.S. Spine Fixation segment saw an 8% increase in net sales, with procedural volume up 10%, driven by the 7D FLASH navigation system and distributor transitions.
Orthopedics Business Growth
The U.S. Orthopedics segment experienced 19% growth, marking the fifth consecutive quarter of double-digit growth, fueled by the successful global launch of TrueLok Elevate.
Bone Growth Therapies Achievement
Bone Growth Therapies achieved 6% growth, outperforming the market, supported by cross-selling opportunities.
Positive Free Cash Flow
Orthofix generated a positive free cash flow of $2.5 million, ending the quarter with $65.9 million in total cash, supporting continued innovation and financial flexibility.
EBITDA Margin Expansion
The company reported its seventh consecutive quarter of adjusted EBITDA margin expansion, highlighting operational efficiency and cost management.

Orthofix (OFIX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

OFIX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 03, 2026
2025 (Q4)
-0.19 / -
-0.75
Nov 04, 2025
2025 (Q3)
-0.56 / -0.57
-0.7119.72% (+0.14)
Jun 30, 2025
2025 (Q2)
-0.49 / -0.36
-0.8859.09% (+0.52)
May 06, 2025
2025 (Q1)
-0.55 / -1.35
-0.95-42.11% (-0.40)
Feb 25, 2025
2024 (Q4)
-0.29 / -0.75
-0.59-27.12% (-0.16)
Nov 07, 2024
2024 (Q3)
-0.34 / -0.71
0.07-1114.29% (-0.78)
Aug 06, 2024
2024 (Q2)
-0.36 / -0.88
0.02-4500.00% (-0.90)
May 07, 2024
2024 (Q1)
-0.51 / -0.95
-0.1-850.00% (-0.85)
Mar 05, 2024
2023 (Q4)
0.06 / -0.59
0.19-410.53% (-0.78)
Nov 08, 2023
2023 (Q3)
-0.21 / 0.07
0.13-46.15% (-0.06)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

OFIX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 04, 2025
$16.06$14.87-7.41%
Jun 30, 2025
$11.09$11.15+0.54%
May 06, 2025
$13.54$12.06-10.93%
Feb 25, 2025
$18.15$17.51-3.53%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Orthofix International (OFIX) report earnings?
Orthofix International (OFIX) is schdueled to report earning on Mar 03, 2026, After Close (Confirmed).
    What is Orthofix International (OFIX) earnings time?
    Orthofix International (OFIX) earnings time is at Mar 03, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is OFIX EPS forecast?
          OFIX EPS forecast for the fiscal quarter 2025 (Q4) is -0.19.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis